A girl with duplication 17p10‐p12 associated with a dicentric chromosome

We report a 7½‐year‐old girl with an ∼9.5 Mb duplication of proximal 17p. Her clinical features include moderately severe developmental delay, absence of speech, talipes, congenital dislocation of the hips, premature adrenarche, dysmorphic facial features, deep palmar creases, and signs and symptoms of peripheral neuropathy consistent with Charcot–Marie–Tooth disease type 1A (CMT1A). Chromosome analysis revealed a partially duplicated 17p with two centromeres on the derivative chromosome. Fluorescence in situ hybridization (FISH) analysis demonstrated the tandemly duplicated segment spans 17p10‐p12, including the entire Smith–Magenis syndrome (SMS) critical region and a portion of the CMT1A critical region. One breakpoint mapped within the centromere and the second breakpoint mapped within the CMT1A critical region, distal to the PMP22 gene. Microsatellite polymorphism studies showed that the duplicated chromosome is of maternal origin. We compare the clinical features of our patient to those of individuals with partial trisomy of proximal 17p to further delineate the genotype–phenotype correlation associated with segmental duplication of this chromosomal region. © 2003 Wiley‐Liss, Inc.

[1]  J. Farnham,et al.  Charcot-Marie-Tooth disease 1A (CMT1A) associated with a maternal duplication of chromosome 17p11.2→12 , 1993, Human Genetics.

[2]  A. Daniel.  Single Cd band in dicentric translocations with one suppressed centromere , 1979, Human Genetics.

[3]  L. Shaffer,et al.  A clinical and molecular study of mosaicism for trisomy 17 , 2004, Human Genetics.

[4]  J. Lupski,et al.  Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) Contiguous Gene Syndromes by Chromosome Engineering in Mice: Phenotypic Consequences of Gene Dosage Imbalance , 2003, Molecular and Cellular Biology.

[5]  L. Shaffer,et al.  Genome architecture catalyzes nonrecurrent chromosomal rearrangements. , 2003, American journal of human genetics.

[6]  J. Lupski.  Genomic Disorders: Recombination-Based Disease Resulting from Genome Architecture * * Previously pre , 2003 .

[7]  J. Lupski,et al.  Molecular mechanisms for genomic disorders. , 2003, Annual review of genomics and human genetics.

[8]  J. Lupski,et al.  Genetic proof of unequal meiotic crossovers in reciprocal deletion and duplication of 17p11.2. , 2002, American journal of human genetics.

[9]  L. Shaffer,et al.  Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse. , 2002, Genome research.

[10]  P. Stankiewicz,et al.  Genome architecture, rearrangements and genomic disorders. , 2002, Trends in genetics : TIG.

[11]  P. Stankiewicz,et al.  Trisomy 17p10‐p12 resulting from a supernumerary marker chromosome derived from chromosome 17: molecular analysis and delineation of the phenotype , 2001, Clinical genetics.

[12]  B. Birren,et al.  The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes. , 2001, Genome research.

[13]  E. Lemyre,et al.  Stable non-Robertsonian dicentric chromosomes: four new cases and a review , 2001, Journal of medical genetics.

[14]  V. Kimonis,et al.  Mild phenotype due to tandem duplication of l7p11.2. , 2000, American journal of medical genetics.

[15]  L. Shaffer,et al.  Molecular mechanism for duplication 17p11.2— the homologous recombination reciprocal of the Smith-Magenis microdeletion , 2000, Nature Genetics.

[16]  J. P. van Tintelen,et al.  Precarious acrocentric short arm in prenatal diagnosis: no chromosome 14 polymorphism, but trisomy 17p. , 2000, Genetic counseling.

[17]  J. Carey,et al.  Partial trisomy 17p detected by spectral karyotyping , 1999, Clinical genetics.

[18]  M. Varella‐Garcia,et al.  A dup(17)(p11.2p11.2) detected by fluorescence in situ hybridization in a boy with Alport syndrome. , 1999, American journal of medical genetics.

[19]  D. Flannery,et al.  Prenatal diagnosis of a trisomy 17p derived from a de novo non‐mosaic satellited marker , 1998, Clinical genetics.

[20]  J. Lupski,et al.  Charcot‐Marie‐Tooth phenotype produced by a duplicated PMP22 gene as part of a 17P trisomy‐translocation to the X chromosome , 1998, Clinical genetics.

[21]  J. Lupski.  Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. , 1998, Trends in genetics : TIG.

[22]  A. C. Chinault,et al.  Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome , 1997, Nature Genetics.

[23]  L. Shaffer,et al.  Diagnosis of CMT1A duplications and HNPP deletions by interphase FISH: implications for testing in the cytogenetics laboratory. , 1997, American journal of medical genetics.

[24]  C. Schwartz,et al.  Two patients with duplication of 17p11.2: the reciprocal of the Smith-Magenis syndrome deletion? , 1996, American journal of medical genetics.

[25]  J. Lupski,et al.  A 1.5-Mb cosmid contig of the CMT1A duplication/HNPP deletion critical region in 17p11.2-p12. , 1996, Genomics.

[26]  L. Shaffer,et al.  Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type-1A neuropathy , 1996, Human Genetics.

[27]  A. Schinzel,et al.  Trisomy 17p11‐pter: unbalanced pericentric inversion, inv(17)(p11q25) in two patients, unbalanced translocations t(4;17)(q27;pl1) in a newborn and t(4;17)(pl6;p11.2) in a fetus , 1995, Clinical dysmorphology.

[28]  B. Johansson,et al.  Isochromosomes in neoplasia , 1994, Genes, chromosomes & cancer.

[29]  J. Lupski,et al.  Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. , 1994, Human molecular genetics.

[30]  E. Zackai,et al.  46,XX,15p+ documented as dup (17p) by fluorescence in situ hybridization. , 1993, American journal of medical genetics.

[31]  T. Bird,et al.  Trisomy 17p associated with Charcot‐Marie‐Tooth neuropathy type 1A phenotype , 1992, Neurology.

[32]  D. Ledbetter,et al.  Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A , 1992, Nature Genetics.

[33]  P. Lichter,et al.  Chromosome analysis by non-isotopic in situ hybridization. , 1992 .

[34]  C. Kozma,et al.  De novo duplication of 17p [dup(17)(p12----p11.2)]: report of an additional case with confirmation of the cytogenetic, phenotypic, and developmental aspects. , 1991, American journal of medical genetics.

[35]  Aravinda Chakravarti,et al.  DNA duplication associated with Charcot-Marie-Tooth disease type 1A , 1991, Cell.

[36]  J. Schrander,et al.  Trisomy 17p due to a t(8; 17) (p23; p11.2)pat translocation. Case report and review of the literature , 1990, Clinical genetics.

[37]  L. Larson,et al.  Complete trisomy 17p a relatively new syndrome. , 1988, Annales de genetique.

[38]  J. Reiss,et al.  De novo partial duplication of 17p [dup(17)(p12----p11.2)]: clinical report. , 1986, American journal of medical genetics.

[39]  C. Rosenberg,et al.  Deletion of the centromere as a mechanism for achieving stability of a dicentric chromosome. , 1986, Cytogenetics and cell genetics.

[40]  Z. Docherty,et al.  De novo tandem duplication 17p11→cen , 1983 .

[41]  H. Hoyme,et al.  Duplication (17p) in a child with an isodicentric (17p) chromosome. , 1983, American journal of medical genetics.

[42]  I. Matsuda,et al.  Trisomy 17p due to A t(5;17) (p15;p11) pat translocation. , 1982, Annales de genetique.